Life-altering gene transfer therapies for serious disorders of the brain and central nervous system, including Parkinson’s disease, Epilepsy and Huntington’s chorea.
Recent News
Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease More

Neurologix Announces Q1 2010 Financial Results More

Neurologix Announces Year End 2009 Results More
CLINICAL TRIALS
Learn more
© 2010 Neurologix, Inc. Site Map Terms Site design: Schenkel/Stegman